Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.20
-0.20 (-0.53%)
Aug 29, 2025, 2:32 PM CST
-0.53%
Market Cap26.50B
Revenue (ttm)1.60B
Net Income (ttm)-667.63M
Shares Out712.26M
EPS (ttm)-0.93
PE Ration/a
Forward PEn/a
Dividend0.75 (2.02%)
Ex-Dividend DateOct 3, 2025
Volume443,825
Average Volume747,130
Open37.35
Previous Close37.40
Day's Range37.20 - 37.80
52-Week Range30.60 - 52.00
Beta0.42
RSI46.69
Earnings DateAug 12, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.